Yi Le

Yi Le

Auto-generated profile, based on publicly available information

Yi Le

School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
YZYan Zhang
Yan Zhang
QWQin Wang
Qin Wang
LLLuolan Li
Luolan Li
YLYi Le
Yi Le
LLLi Liu
Li Liu
LYLongjia Yan
Longjia Yan
In this paper, a set of 3-methylquniazolinone derivatives were designed, synthesised, and studied the preliminary structure-activity relationship for antiproliferative activities. All target compounds performed significantly inhibitory effects against wild type epidermal growth factor receptor tyrosine kinase (EGFRwt-TK) and tumour cells (A431, A549, MCF-7, and NCI-H1975). In particular, compound 4d 3-fluoro-N-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)phenyl)benzamide showed higher antiproliferative activities against all tumour cells than Gefitinib (IC50 of 3.48, 2.55, 0.87 and 6.42 μM, respectively). Furthermore, compound 4d could induce apoptosis of MCF-7 cells and arrest in G2/M phase at the tested concentration. Molecular docking and ADMET studies showed that compound 4d could closely form many hydrogen bonds with EGFRwt-TK. Therefore, compound 4d is potential to develop as novel anti-cancer drug.

28 January 2024 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
STSan Tu
San Tu
YLYi Le
Yi Le
LYLan Yang
Lan Yang
QYQiong Yi
Qiong Yi
TFTingting Feng
Tingting Feng
LLLi Liu
Li Liu

9 March 2022 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
LYLongjia Yan
Longjia Yan
QWQin Wang
Qin Wang
LLLi Liu
Li Liu
YLYi Le
Yi Le
This paper described our efforts to develop dianilinopyrimidines as novel EGFR inhibitors. All the target compounds were tested for inhibitory effects against wild type EGFR (EGFRwt) and three tumour cells, including A549, PC-3, and HepG2. Some of the compounds performed well in antitumor activities. Especially, compound 4c 2-((2-((4-(3-fluorobenzamido)phenyl)amino)-5-(trifluoromethyl) pyrimidin-4-yl)amino)-N-methylthiophene-3-carboxamide showed higher anti-tumour activities than Gefitinib. The IC50 values of compound 4c against A549, PC-3, and HepG2. reached 0.56 μM, 2.46 μM, and 2.21 μM, respectively. In addition, further studies indicated that compound 4c could induce apoptosis against A549 cells and arrest A549 cells in the G2/M phase. Molecular docking studies showed that compound 4c could closely interact with EGFR. Generally, compound 4c was the potential for developing into an anti-tumour drug.

5 September 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
YZYan Zhang
Yan Zhang
ZLZhiwu Long
Zhiwu Long
LYLongjia Yan
Longjia Yan
LLLi Liu
Li Liu
LYLan Yang
Lan Yang
YLYi Le
Yi Le
Thirty-five compounds with phenylisoxazole scaffold were synthesized via [3+2] cycloaddition. After being evaluated against Xoo , Psa and Xac , 4-nitro-3-phenylisoxazole derivatives were found well antibacterial activities.

3 January 2025 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
TFTingting Feng
Tingting Feng
JYJiaxue Yang
Jiaxue Yang
YWYi Wang
Yi Wang
THTaozhu Hu
Taozhu Hu
LYLongjia Yan
Longjia Yan
LLLi Liu
Li Liu
DTP specifically recognizes F − and allows for quantitative analysis in buffer solutions. In cellular imaging, DTP releases red fluorescence upon F − recognition, enabling the visualization of fluoride within HepG2 cells.

22 July 2024 in Journal of Fluorescence
Verified
Journal Article
Closed access
PDF file
YZYing Zhang
Ying Zhang
TFTingting Feng
Tingting Feng
THTaozhu Hu
Taozhu Hu
YWYi Wang
Yi Wang
YLYi Le
Yi Le